EDGAR Filing Documents for 0001628280-23-016603

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001628280-23-016603

Filing Date

2023-05-09

Accepted

2023-05-09 06:06:22

Documents

104

Period of Report

2023-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	adc-20230331.htm iXBRL	6-K	205620
2	EX-99.1	adc-20230331_d2.htm iXBRL	EX-99.1	1255102
3	EX-99.2	adct-20230331x6kex992.htm	EX-99.2	170897
4	EX-99.3	adct-20230331ex993.htm	EX-99.3	159721
10		image_4.jpg	GRAPHIC	20773
	Complete submission text file	0001628280-23-016603.txt		8621871

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	adc-20230331.xsd	EX-101.SCH	94128
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	adc-20230331_cal.xml	EX-101.CAL	76606
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	adc-20230331_def.xml	EX-101.DEF	369736
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	adc-20230331_lab.xml	EX-101.LAB	710322
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	adc-20230331_pre.xml	EX-101.PRE	529731
98	EXTRACTED XBRL INSTANCE DOCUMENT	adc-20230331_htm.xml	XML	1570521

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066

Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00

ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)